Sientra (NASDAQ:SIEN – Get Rating) will be posting its quarterly earnings results after the market closes on Thursday, August 11th. Analysts expect Sientra to post earnings of ($0.23) per share for the quarter. Sientra has set its FY 2022 guidance at EPS.Parties interested in participating in the company's conference call can do so using this link.
Sientra (NASDAQ:SIEN – Get Rating) last announced its quarterly earnings data on Thursday, May 12th. The medical instruments supplier reported ($0.29) EPS for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.03). Sientra had a negative net margin of 71.61% and a negative return on equity of 498.54%. The firm had revenue of $21.40 million during the quarter, compared to analysts' expectations of $20.25 million. On average, analysts expect Sientra to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Get Sientra alerts:Sientra Trading Up 7.1 %
Shares of NASDAQ:SIEN opened at $1.06 on Thursday. Sientra has a 52 week low of $0.70 and a 52 week high of $7.95. The company's 50 day moving average is $0.92 and its two-hundred day moving average is $1.77. The company has a current ratio of 1.59, a quick ratio of 0.95 and a debt-to-equity ratio of 2.61. The company has a market cap of $66.40 million, a PE ratio of -1.07 and a beta of 1.94.
Institutional Trading of Sientra
Large investors have recently bought and sold shares of the business. Mirabella Financial Services LLP acquired a new stake in Sientra during the 1st quarter worth $26,000. Advisor Group Holdings Inc. lifted its stake in shares of Sientra by 230.9% in the 1st quarter. Advisor Group Holdings Inc. now owns 11,930 shares of the medical instruments supplier's stock worth $26,000 after acquiring an additional 8,325 shares during the period. Bank of Montreal Can lifted its stake in shares of Sientra by 66.7% in the 1st quarter. Bank of Montreal Can now owns 66,589 shares of the medical instruments supplier's stock worth $151,000 after acquiring an additional 26,649 shares during the period. Blair William & Co. IL lifted its stake in shares of Sientra by 20.1% in the 1st quarter. Blair William & Co. IL now owns 77,645 shares of the medical instruments supplier's stock worth $172,000 after acquiring an additional 13,000 shares during the period. Finally, Panagora Asset Management Inc. acquired a new stake in shares of Sientra in the 1st quarter worth $182,000. Institutional investors and hedge funds own 82.42% of the company's stock.Analyst Ratings Changes
SIEN has been the topic of a number of recent analyst reports. Lake Street Capital started coverage on shares of Sientra in a research report on Thursday, April 14th. They issued a "buy" rating and a $8.00 price objective on the stock. Maxim Group reaffirmed a "buy" rating and issued a $5.00 target price on shares of Sientra in a research report on Friday, May 13th. StockNews.com downgraded shares of Sientra from a "hold" rating to a "sell" rating in a research report on Tuesday, May 10th. Finally, Canaccord Genuity Group dropped their target price on shares of Sientra from $8.00 to $5.00 in a research report on Friday, May 13th. One analyst has rated the stock with a sell rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, Sientra has a consensus rating of "Moderate Buy" and a consensus target price of $7.29.
About Sientra
(Get Rating)
Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.
See Also
- Get a free copy of the StockNews.com research report on Sientra (SIEN)
- There Are Different Types of Stock To Invest In
- Is it Time to Tap Molson Coors or Will Beer Sales Turn Flat?
- Is Starbucks Shooting For The Moon?
- PayPal Continues To Struggle As Competition Increases
- Two High-Yield Deep-Values You Shouldn't Ignore
Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.